386 related articles for article (PubMed ID: 26482411)
1. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.
Bai M; Zhou M; He L; Ma F; Li Y; Yu Y; Wang P; Li L; Jing R; Zhao L; Sun S
Intensive Care Med; 2015 Dec; 41(12):2098-110. PubMed ID: 26482411
[TBL] [Abstract][Full Text] [Related]
2. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
Liu C; Mao Z; Kang H; Hu J; Zhou F
Crit Care; 2016 May; 20(1):144. PubMed ID: 27176622
[TBL] [Abstract][Full Text] [Related]
3. [Regional citrate versus heparin anticoagulation in continuous renal replacement therapy in critically ill patients: a Meta-analysis].
Feng X; Deng L; Zhang Y; Chang L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):982-987. PubMed ID: 32912414
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
5. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy.
Liao YJ; Zhang L; Zeng XX; Fu P
Chin Med J (Engl); 2013 Apr; 126(7):1344-9. PubMed ID: 23557569
[TBL] [Abstract][Full Text] [Related]
6. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
[TBL] [Abstract][Full Text] [Related]
7. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
Oudemans-van Straaten HM
Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
[TBL] [Abstract][Full Text] [Related]
8. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis of randomized controlled trials.
Li R; Gao X; Zhou T; Li Y; Wang J; Zhang P
Ther Apher Dial; 2022 Dec; 26(6):1086-1097. PubMed ID: 35385216
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
Zhou Z; Liu C; Yang Y; Wang F; Zhang L; Fu P
Crit Care; 2023 Jun; 27(1):222. PubMed ID: 37287084
[TBL] [Abstract][Full Text] [Related]
10. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.
Tillman J
Nurs Crit Care; 2009; 14(4):191-9. PubMed ID: 19531037
[TBL] [Abstract][Full Text] [Related]
11. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
[TBL] [Abstract][Full Text] [Related]
12. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
[TBL] [Abstract][Full Text] [Related]
13. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
[TBL] [Abstract][Full Text] [Related]
14. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
Sık G; Demirbuga A; Annayev A; Citak A
Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
[TBL] [Abstract][Full Text] [Related]
15. Regional citrate anticoagulation for continuous renal replacement therapy in children.
Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
[TBL] [Abstract][Full Text] [Related]
16. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
Davis TK; Neumayr T; Geile K; Doctor A; Hmeil P
Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
[TBL] [Abstract][Full Text] [Related]
18. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
[TBL] [Abstract][Full Text] [Related]
19. Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice.
Tovey L; Dickie H; Gangi S; Terblanche M; McKenzie C; Beale R; Treacher D; Ostermann M
Nephron Clin Pract; 2013; 124(1-2):119-23. PubMed ID: 24281234
[TBL] [Abstract][Full Text] [Related]
20. Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Jacobs R; Verbrugghe W; Dams K; Roelant E; Couttenye MM; Devroey D; Jorens P
Life (Basel); 2023 May; 13(5):. PubMed ID: 37240843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
